SCHEMBL11329633

SCHEMBL11329633

c1cnc(-c2ncc3ccccc3n2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.58
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 3/20 0.43
GPR3 P46089 1/20 0.43
EGFR P00533 1/20 0.43
NPC1 O15118 3/20 0.43
MAPT P10636 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
ACHE P22303 1/20 0.41
HTR3A P46098 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GRM5 P41594 1/20 0.39
KCNH2 Q12809 1/20 0.39
METAP1 P53582 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30198446 0.91 CYP1A2 (0.60) CYP1A2ALDH1A1KDM4EGPR3EGFR
SCHEMBL1672650 0.91 CYP1A2 (0.60) CYP1A2ALDH1A1KDM4EGPR3EGFR
SCHEMBL30527184 0.91 CYP1A2 (0.60) CYP1A2ALDH1A1KDM4EGPR3EGFR
SCHEMBL13911016 0.82 CYP1A2 (0.56) CYP1A2ALDH1A1KDM4EGPR3EGFR
SCHEMBL29784044 0.82 KDM4E (0.57) CYP1A2ALDH1A1KDM4ENPC1MAPT
SCHEMBL45359 0.82 KDM4E (0.57) CYP1A2ALDH1A1KDM4ENPC1MAPT
SCHEMBL713218 0.78 CYP1A2 (0.66) CYP1A2KDM4EGPR3NPC1MAPT
SCHEMBL14099190 0.78 CYP1A2 (0.53) CYP1A2ALDH1A1KDM4EGPR3EGFR
SCHEMBL31325779 0.78 CYP1A2 (0.66) CYP1A2KDM4EGPR3NPC1MAPT
SCHEMBL18806864 0.78 CYP1A2 (0.61) CYP1A2ALDH1A1KDM4EGPR3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0037495-A1 Pyrimidyl quinazolines, process for their preparation and pharmaceutical compositions containing them CASSELLA Aktiengesellschaft (DE) 1981-10-14 EP claimed
EP-2665475-A2 N-ARYLAMINOMETHYLENE BENZOTHIOPHENONES FOR TREATMENT OF CARDIOVASCULAR DISEASE Max-Delbrück-Centrum für Molekulare Medizin Berlin-Buch (DE) 2013-11-27 EP disclosed
WO-2012098172-A2 N-ARYLAMINOMETHYLENE BENZOTHIOPHENONES FOR TREATMENT OF CARDIOVASCULAR DISEASE Max-Delbrück-Centrum für Molekulare Medizin (DE) 2012-07-26 WO disclosed
EP-0037495-A1 Pyrimidyl quinazolines, process for their preparation and pharmaceutical compositions containing them CASSELLA Aktiengesellschaft (DE) 1981-10-14 EP disclosed
EP-0037495-A1 Pyrimidyl quinazolines, process for their preparation and pharmaceutical compositions containing them CASSELLA Aktiengesellschaft (DE) 1981-10-14 EP disclosed
EP-0037495-A1 Pyrimidyl quinazolines, process for their preparation and pharmaceutical compositions containing them CASSELLA Aktiengesellschaft (DE) 1981-10-14 EP disclosed